Grakova, E. V., Kopeva, K. V., Teplyakov, A. T., Soldatenko, M. V., Suslova, T. E., & Kalyuzhin, V. V. (2022). Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction. Бюллетень сибирской медицины, 21(1), 35-46. https://doi.org/10.20538/1682-0363-2022-1-35-46
Chicago-referens (17:e uppl.)Grakova, E. V., K. V. Kopeva, A. T. Teplyakov, M. V. Soldatenko, T. E. Suslova, och V. V. Kalyuzhin. "Effect of β-blocker Therapy on the Level Soluble ST2 Protein in the Blood Serum in Patients with Heart Failure with Preserved and Mildly Reduced Ejection Fraction." Бюллетень сибирской медицины 21, no. 1 (2022): 35-46. https://doi.org/10.20538/1682-0363-2022-1-35-46.
MLA-referens (9:e uppl.)Grakova, E. V., et al. "Effect of β-blocker Therapy on the Level Soluble ST2 Protein in the Blood Serum in Patients with Heart Failure with Preserved and Mildly Reduced Ejection Fraction." Бюллетень сибирской медицины, vol. 21, no. 1, 2022, pp. 35-46, https://doi.org/10.20538/1682-0363-2022-1-35-46.
